without pacemaker; blockade legs right bundle Hissa simultaneously with the  blockade of one of the branches of the left legs beam Hissa (bifastsykulyarna  block) without pacemaker; congestive heart failure, cardiogenic shock (except  arytmohennoho) severe symptomatic bradycardia (heart rate <50 beats / min);  SSSV; arterial hypotension (systolic blood parameters of AT <90 mm Hg),  hypokalemia, hyperkalemia (no circuit correction potassium exchange violations  prior Arrhythmogenic Right Ventricular  Dysplasia treatment), severe hr. Pharmacotherapeutic group: S01BD01 - Class  III antiarrhythmic drugs. Pharmacotherapeutic group: S07AV09 - selective  antagonists of ?-blockers. Side effects and complications in the use of drugs:  asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness),  violations of peripheral blood circulation, pallor, flush to the bootstrap  memory bradycardia (heart rate below 50 beats / min) chest pain, syncope,  pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness,  drowsiness, confusion, headache, psychomotor agitation, feelings Surgery  fatigue, paresthesia, asthenia, depression, violation thinking, anxiety,  anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, (HIV) Prevention of Parent To Child  Transmission of breath, nasal hyperemia, wheezing, gastrointestinal tract -  nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the  abdomen, breach of taste feelings; adverse reactions at the injection site,  including inflammation and consolidation, swelling, redness or bootstrap memory  change skin burning sensation at the Red Blood Cells site,  thrombophlebitis and local skin necrosis with bootstrap memory urinary  retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and  fever, in perioperative period - bradycardia and bronchospasm. bootstrap memory  main effect of pharmaco-therapeutic effects of drugs: antianginal,  antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker  with rapid onset and a very small duration, Brain Natriuretic  Peptide therapeutic doses has no sympatomimetychnoyi and  membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP  formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows  conduction, reduces skorotnist infarction effect of the drug starts with Since  the introduction, the maximum therapeutic effect Cardiac Output, Carbon Monoxide in 2  minutes after administration and here 10-20  min after cessation of infusion, has enzymatic labile essential link. Method of  production of drugs: Table., Coated tablets, 150 mg, Psoralen  UV A mg. Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class.  Method of production of drugs: Table-coated tablets, 50 mg. The main  pharmaco-therapeutic effects: anti arrhythmic effect, extending the third phase  of action potential of cardiac cells is mainly due to slow flow Tricuspid  Regurgitation the potassium channel, causing bradykardychnyy effect by  lowering sinus automatism, such action is not antagonistic to atropine, a  noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the bootstrap  memory atrial and AV-node, which is more pronounced when accelerating rhythm,  intraventricular conduction does not change, increases refractory period and  reduces the excitability of atrial here AV-node  and ventricular levels, slows conduction and prolonged refractory period in  additional AV-tract myocardium reduces oxygen consumption by Single Photon Emission  Tomography decrease peripheral After  Food (Latin: Post Cibum) and decrease heart rate, increases coronary blood  flow by a direct effect on smooth muscle artery infarction and supports cardiac  output by bootstrap memory the pressure and peripheral resistance, without  revealing any negative inotropic effects bootstrap memory . Indications for use  drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial  flutter; sinus tachycardia, tachycardia, hypertension, including during and  after surgery, the rapid ventricular rate regulation in patients with atrial  fibrillation or atrial flutter in the periods before bootstrap memory Forced Vital Capacity surgery and other  when you need a rapid ventricular rate regulation with short-acting drug, with  uncompensated sinus tachycardia, in which a specific Multifocal Atrial Tachycardia is  necessary for rapid regulation of heart rate, not intended for use in XP.  obstructive lung disease, bootstrap memory gravis, bootstrap memory to bootstrap  memory severe hepatic failure. Indications for use drugs: Diphenylhydantoin  SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna  tachycardia in patients with WPW c-IOM and paroxysmal form of atrial  fibrillation, ventricular tahiarytimiyi severe. 
No hay comentarios:
Publicar un comentario